Skip to content
Aminoscope
← Research
GLP-1

Metformin vs Ozempic: different drugs, often used together

Not really rivals — metformin is the cheap, oral, first-line foundation; Ozempic (semaglutide) is a more potent injectable that adds greater glucose-lowering and real weight loss.

Julian Roth6 min read
Metformin and Ozempic: two drug classes that both lower glucoseglucosecontrolmetforminoral · first-lineOzempicinjected · GLP-1weight ↓TWO CLASSES · METFORMIN FIRST, GLP-1 ADDS MORE

“Metformin vs Ozempic” is a slightly misleading framing, because the two aren’t competing for the same job. They’re different classes of drug, with different strengths, and in real diabetes care they’re frequently used together. The useful question isn’t which wins — it’s what each one is for.

Two different drugs, two different jobs

Metformin is a biguanide — an inexpensive oral pill that lowers glucose mainly by reducing the liver’s sugar output, with decades of safety data and a near-neutral effect on weight. Ozempic is semaglutide, a GLP-1 receptor agonist — a once-weekly injection that lowers glucose and powerfully reduces appetite. They lower blood sugar through completely different mechanisms, which is exactly why they combine well.

What the numbers show

In the SUSTAIN-2 trial, adding semaglutide to background therapy cut HbA1c by 1.3 to 1.6 percentage points and reduced body weight by 4.3 to 6.1 kg (at the 0.5 and 1.0 mg doses) — substantially more than the comparator.[1] Metformin’s glucose-lowering is real but more modest, and it doesn’t produce that kind of weight loss. So on raw potency for both blood sugar and weight, semaglutide wins clearly.

Metformin's edge is cost, simplicity and a long safety record; semaglutide's edge is greater glucose-lowering and real weight loss.
MetforminOzempic (semaglutide)
ClassBiguanideGLP-1 receptor agonist
RouteOral, dailyInjection, weekly
Glucose-loweringModest, reliableGreater (−1.3 to −1.6 pts added)
Weight≈ neutralMeaningful loss (4–6 kg)
CostVery low (generic)High
Track recordDecades, first-lineNewer, potent
Metformin's edge is cost, simplicity and a long safety record; semaglutide's edge is greater glucose-lowering and real weight loss. SUSTAIN-2 (PMID 28385659); ADA Standards of Care (PMID 38078590)

The honest verdict

If you’re forced to compare them head to head, semaglutide is the more powerful drug for both blood sugar and weight — but metformin is cheaper, oral, weight-neutral, and carries a safety record semaglutide can’t yet match, which is why it remains a first-line foundation for many people.[1][2] For most patients the realistic path is metformin first, GLP-1 added when needed — not one instead of the other. Note this is Ozempic, the diabetes brand; for weight loss specifically the semaglutide brand is Wegovy (see Ozempic vs Wegovy). If metformin’s longevity angle interests you, see metformin and longevity; to compare GLP-1 options, our GLP-1 comparison tool and provider guide.

Reviewed against primary sources by the Aminoscope desk

Frequently asked

What is the difference between metformin and Ozempic?
Metformin is an inexpensive oral biguanide pill that lowers blood sugar mainly by reducing the liver's glucose output, and it is roughly weight-neutral. Ozempic is semaglutide, a once-weekly GLP-1 injection that lowers glucose through a different mechanism and also curbs appetite. Because they work in different ways, doctors often pair them rather than pick one over the other.
Is metformin or Ozempic better for weight loss?
Ozempic (semaglutide) is clearly the stronger option for weight loss. In the SUSTAIN-2 trial, adding semaglutide reduced body weight by roughly 4.3 to 6.1 kg, whereas metformin is essentially weight-neutral and does not produce that kind of drop. If meaningful weight loss is the goal, the GLP-1 is more potent, though it is injected weekly rather than taken as a daily pill.
Can you take metformin and Ozempic together?
Yes, and in practice they are frequently used together rather than as an either/or choice. Because metformin and semaglutide lower blood sugar through completely different mechanisms, they combine well. A common path is metformin as the oral foundation, with Ozempic added when more glucose control or weight loss is needed. Follow your prescriber's guidance on dosing and timing.
Is metformin cheaper than Ozempic?
Yes. Metformin is a decades-old generic available at a very low cost, which is part of why it remains a first-line foundation for type-2 diabetes. Ozempic (semaglutide) is a newer, more potent branded injection and is considerably more expensive. That cost gap is one of metformin's main advantages, alongside its long safety record and simple oral dosing.

Sources

  1. [1] Ahrén B, Masmiquel L, Kumar H, et al. (2017). Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial. Lancet Diabetes Endocrinol. PMID 28385659
  2. [2] American Diabetes Association Professional Practice Committee. (2024). 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2024. Diabetes Care. PMID 38078590

Related tool

GLP-1 weight-loss comparison

See semaglutide, tirzepatide, retatrutide and the pipeline ranked by mean trial weight loss — every figure traced to its source.

More in GLP-1